crataegus oxyacantha extract
extract of the whole plant of the hawthorn, crataegus oxyacantha (l.), rosaceae
Identification
| Name | crataegus oxyacantha extract |
| IUPAC | crataegus oxyacantha l. extract |
| CAS Number | 84603-61-2 |
| FDA UNII | Search |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | skin conditioning |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | cosmetic agents, dietary supplements |
| Recommendation for crataegus oxyacantha extract usage levels up to | not for fragrance use. |
Potential Uses
Natural Occurrence
Synonyms
crataegus curvisepala extract
crataegus extract (crataegus oxyacantha)
extract of crataegus
extract of the whole plant of the hawthorn, crataegus oxyacantha (l.), rosaceae
hawthorn extract
hawthorne extract
PubMed:
Phytochemical attributes of four conventionally extracted medicinal plants and cytotoxic evaluation of their extracts on human laryngeal carcinoma (HEp2) cells.
PubMed:
Hawthorn (Crataegus oxyacantha L.) bark extract regulates antioxidant response element (ARE)-mediated enzyme expression via Nrf2 pathway activation in normal hepatocyte cell line.
PubMed:
Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage.
PubMed:
Immunomodulatory effect of Hawthorn extract in an experimental stroke model.
PubMed:
Crataegus oxyacantha (Hawthorn). Monograph.
PubMed:
Preclinical toxicological assessment of a phytotherapeutic product--CPV (based on dry extracts of Crataegus oxyacantha L., Passiflora incarnata L., and Valeriana officinalis L.).
PubMed:
Synergistic effect of tincture of Crataegus and Mangifera indica L. extract on hyperlipidemic and antioxidant status in atherogenic rats.
PubMed:
Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract.
PubMed:
[An orientational examination of the effects of extracts from mixtures of herbal drugs on selected renal functions].
PubMed:
Hawthorn evokes a potent anti-hyperglycemic capacity in streptozotocin-induced diabetic rats.
PubMed:
Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders.
PubMed:
A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
PubMed:
Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha).
PubMed:
Hawthorn: pharmacology and therapeutic uses.
PubMed:
Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats.
PubMed:
Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta.
PubMed:
Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart.
PubMed:
Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (Hawthorn) flower heads.
PubMed:
Hypolipidemic activity of tincture of Crataegus in rats.
PubMed:
[Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them].
PubMed:
[Predictability of the activity of drug combinations--yes or no (author's transl)].
PubMed:
[Effect of Crataegus oxyacantha extract on the coronary blood flow in dogs].
PubMed:
[Electrocardiographic effects of a Crataegus oxyacantha extract].